Paper32047367
Complex Combination Pharmacotherapy for Bipolar Disorder: Knowing When Less Is More or More Is Better.
Goldberg JF. Focus (Am Psychiatr Publ), 2019. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Complex Combination Pharmacotherapy for Bipolar Disorder: Knowing When Less Is More or More Is Better. Papers, record 32047367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32047367
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Complex Combination Pharmacotherapy for Bipolar Disorder: Knowing When Less Is More or More Is Better.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References109
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22163329 | Prescribing trends in bipolar disorder: cohort study in the United Kingdom THIN primary care database 1995-2009. | PLoS One | 2011 | https://conductscience.org/library/papers/22163329 | PubMed |
| 2 | 26992156 | Polypharmacy in Maintenance of Bipolar Disorder. | Clin Neuropharmacol | 2016 | https://conductscience.org/library/papers/26992156 | PubMed |
| 3 | 27856422 | Allopurinol as add-on treatment for mania symptoms in bipolar disorder: systematic review and meta-analysis of randomised controlled trials. | Br J Psychiatry | 2017 | https://conductscience.org/library/papers/27856422 | PubMed |
| 4 | 17628508 | Chronic carbamazepine administration reduces N-methyl-D-aspartate receptor-initiated signaling via arachidonic acid in rat brain. | Biol Psychiatry | 2007 | https://conductscience.org/library/papers/17628508 | PubMed |
| 5 | 19210946 | Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD. | J Clin Psychiatry | 2009 | https://conductscience.org/library/papers/19210946 | PubMed |
| 6 | 20122366 | A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II). | J Clin Psychiatry | 2010 | https://conductscience.org/library/papers/20122366 | PubMed |
| 7 | 21492946 | The NMDA receptor/nitric oxide pathway: a target for the therapeutic and toxic effects of lithium. | Trends Pharmacol Sci | 2011 | https://conductscience.org/library/papers/21492946 | PubMed |
| 8 | 23107222 | Lamotrigine as add-on treatment to lithium and divalproex: lessons learned from a double-blind, placebo-controlled trial in rapid-cycling bipolar disorder. | Bipolar Disord | 2012 | https://conductscience.org/library/papers/23107222 | PubMed |
| 9 | 16985186 | The mechanism of activity-dependent sodium channel inhibition by the antidepressants fluoxetine and desipramine. | Mol Pharmacol | 2006 | https://conductscience.org/library/papers/16985186 | PubMed |
| 10 | 20092882 | Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. | Lancet | 2010 | https://conductscience.org/library/papers/20092882 | PubMed |
| 11 | 23288387 | Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium. | Am J Psychiatry | 2013 | https://conductscience.org/library/papers/23288387 | PubMed |
| 12 | 24170221 | Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study. | Am J Psychiatry | 2014 | https://conductscience.org/library/papers/24170221 | PubMed |
| 13 | 30549489 | A Double-Blind, Randomized, Placebo-Controlled Study of Aspirin and N-Acetylcysteine as Adjunctive Treatments for Bipolar Depression. | J Clin Psychiatry | 2018 | https://conductscience.org/library/papers/30549489 | PubMed |
| 14 | 10826666 | Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness. | J Clin Psychiatry | 2000 | https://conductscience.org/library/papers/10826666 | PubMed |
| 15 | 17355728 | Use of treatment guidelines in clinical decision making in bipolar disorder: a pilot survey of clinicians. | Curr Med Res Opin | 2007 | https://conductscience.org/library/papers/17355728 | PubMed |
| 16 | 15117400 | Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study. | Bipolar Disord | 2004 | https://conductscience.org/library/papers/15117400 | PubMed |
| 17 | 15126120 | Antipsychotic drugs clozapine and olanzapine upregulate bcl-2 mRNA and protein in rat frontal cortex and hippocampus. | Brain Res | 2004 | https://conductscience.org/library/papers/15126120 | PubMed |
| 18 | 29536616 | Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. | Bipolar Disord | 2018 | https://conductscience.org/library/papers/29536616 | PubMed |
| 19 | 17196048 | Adjunctive topiramate therapy in patients receiving a mood stabilizer for bipolar I disorder: a randomized, placebo-controlled trial. | J Clin Psychiatry | 2006 | https://conductscience.org/library/papers/17196048 | PubMed |
| 20 | 18346292 | A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder. | Int J Neuropsychopharmacol | 2008 | https://conductscience.org/library/papers/18346292 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42541691 | Trajectories of psychotropic drug use patterns in psychiatric inpatients with acute depressive episodes of bipolar disorder: results from a pharmacovigilance program in German-speaking countries from 2007 to 2024. | Int J Bipolar Disord | 2026 | https://conductscience.org/library/papers/42541691 | PubMed |
| 42479879 | Optimizing Treatment Strategies in the Bipolar Disorder Spectrum With Classical AI Approaches: Systematic Review of Performance, Bias, and Clinical Applicability. | JMIR Ment Health | 2026 | https://conductscience.org/library/papers/42479879 | PubMed |
| 42351613 | Pharmacotherapeutic Options in Drug-Resistant Bipolar Depression: From Molecular Mechanisms to Rational Polypharmacotherapy. | Biomedicines | 2026 | https://conductscience.org/library/papers/42351613 | PubMed |
| 40649910 | Plasma and Serum LC-MS Lipidomic Fingerprints of Bipolar Disorder and Schizophrenia. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40649910 | PubMed |
| 39438154 | Early use of long-acting injectable antipsychotics in bipolar disorder type I: An expert consensus. | Bipolar Disord | 2025 | https://conductscience.org/library/papers/39438154 | PubMed |
| 38847247 | Pharmacological Mechanism of Herbal Interventions for Bipolar Disorder. | Curr Pharm Des | 2024 | https://conductscience.org/library/papers/38847247 | PubMed |
| 38765068 | Benson relaxation technique to address sleep quality and aggression among patients with bipolar type I disorder: A randomized clinical trial study. | Heliyon | 2024 | https://conductscience.org/library/papers/38765068 | PubMed |
| 38695001 | Bipolar Disorder Among Older Adults: Newer Evidence to Guide Clinical Practice. | Focus (Am Psychiatr Publ) | 2023 | https://conductscience.org/library/papers/38695001 | PubMed |
| 36825703 | Pharmacological Strategies for Bipolar Disorders in Acute Phases and Chronic Management with a Special Focus on Lithium, Valproic Acid, and Atypical Antipsychotics. | Curr Neuropharmacol | 2023 | https://conductscience.org/library/papers/36825703 | PubMed |
| 36269465 | Efficacy and safety of adjunctive therapy to lamotrigine, lithium, or valproate monotherapy in bipolar depression: a systematic review and meta-analysis of randomized controlled trials. | Int J Bipolar Disord | 2022 | https://conductscience.org/library/papers/36269465 | PubMed |
| 33623386 | Real-World Patterns of Utilization and Costs Associated with Second-Generation Oral Antipsychotic Medication for the Treatment of Bipolar Disorder: A Literature Review. | Neuropsychiatr Dis Treat | 2021 | https://conductscience.org/library/papers/33623386 | PubMed |
| 32047366 | Personalized Pharmacotherapy for Bipolar Disorder: How to Tailor Findings From Randomized Trials to Individual Patient-Level Outcomes. | Focus (Am Psychiatr Publ) | 2019 | https://conductscience.org/library/papers/32047366 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32047367
GET https://conductscience.org/api/papers/v1/32047367/references?page=2